Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetaminophen prevention of loxoprofen-induced small intestinal mucosal injury in healthy volunteers
jRCTs051240184Not yet recruiting
- Sponsor
- Lion Corporation
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of acetaminophen and loxoprofen in non-steroidal anti-inflammatory drug-induced enteropathy (NSAID-E) (2 arms), sponsored by Lion Corporation. Primary endpoint: Number of small intestinal mucosal injuries. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
acetaminophenloxoprofen
03
Conditions
non-steroidal anti-inflammatory drug-induced enteropathy (NSAID-E)
Beyond the preview
Go deeper on jRCTs051240184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051240184.